🇺🇸 FDA
Pipeline program

Combination of MK3475 with Metronomic CP

IB 2014-04

Phase 2 small_molecule completed

Quick answer

Combination of MK3475 with Metronomic CP for Sarcoma is a Phase 2 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Design Therapeutics
Indication
Sarcoma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials